e-learning
resources
Madrid 2019
Sunday, 29.09.2019
CCC Respiratory critical care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Kocuria species: an emerging bacterial infection in critical ill patients
R. Fittipaldi Palazzo (Rio De Janeiro (RJ), Brazil)
Source:
International Congress 2019 – CCC Respiratory critical care
Session:
CCC Respiratory critical care
Session type:
Challenging clinical cases
Number:
181
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Fittipaldi Palazzo (Rio De Janeiro (RJ), Brazil). Kocuria species: an emerging bacterial infection in critical ill patients. International Congress 2019 – CCC Respiratory critical care
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Related content which might interest you:
Antibiotics reduce dual pathogen isolates more than single pathogen isolates following COPD exacerbation
Source: Annual Congress 2009 - Exacerbations of COPD: new findings
Year: 2009
Predicting bacteraemia or rapid identification of the causative pathogen in community acquired pneumonia: where should the priority lie?
Source: Eur Respir J 2016; 48: 619-622
Year: 2016
Carbapenem-resistant pathogens in US patients hospitalized with respiratory infections
Source: International Congress 2018 – Clinical challenges in respiratory infection
Year: 2018
Are there differences in Pneumonia sp. pneumoniae in patients with community-acquired pneumonia patients and institutionalized?
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009
Impact of
candida
spp. colonization of respiratory tract in patients with intensive care unit-acquired pneumonia
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Clinical outcomes of tigecycline in the treatment of critically ill patients with multidrug-resistant Acinetobactor baumannii infection
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011
The emerging problem of
Aspergillus
spp. infections in the respiratory patient
Source: Annual Congress 2005 - Difficult infections in the respiratory patient
Year: 2005
Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis
Source: Eur Respir J 2015; 45: 1353-1363
Year: 2015
Ventilator-associated pneumonia (VAP) pathogenic microorganisms eradication and persistence during antimicrobial therapy
Source: Annual Congress 2013 –Recent developments in pneumonia
Year: 2013
Is Chlamydia pneumoniae an important pathogen in patients with community-acquired pneumonia?
Source: Eur Respir J 2003; 21: 741-742
Year: 2003
The role of MBL in
B. cepacia
infections in CF patients
Source: Eur Respir J 2005; 26: Suppl. 49, 403s
Year: 2005
Identifying patients with pneumonia due to MDR organisms coming from the community
Source: Eur Respir Monogr 2017; 75: 97-110
Year: 2017
Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia
Source: Eur Respir J 2007; 29: 548-560
Year: 2007
Virusologic research in healthy persons of closed collectives
Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections
Year: 2005
Melioidosis: an important cause of pneumonia in residents of and travellers returned from endemic regions
Source: Eur Respir J 2003; 22: 542-550
Year: 2003
Carbapenemase producing Klebsiella pneumoniae (KPC+) colonization/infection in a respiratory intensive care unit: Prevalence, length of stay(LOS) and mortality
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014
Imaging patterns of bacterial community acquired pneumonia in moderately immunocompromised patients
Source: Annual Congress 2009 - Old and new: technique and pathology
Year: 2009
Acinetobacter baumanii and Stenotrophomonas maltophilia are associated with lower airway infections in tracheostomised children and young adults.
Source: International Congress 2017 – New insights into paediatric respiratory infections
Year: 2017
Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017
Acinetobacter baumannii infection and colonization among pediatric patients in pediatric ICU and other ICUs
Source: International Congress 2018 – Neonatology and paediatric intensive care
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept